Deriving risks of Down's syndrome from nuchal translucency measurements
- PMID: 10658286
- DOI: 10.1046/j.1469-0705.1999.14060438.x
Deriving risks of Down's syndrome from nuchal translucency measurements
Comment on
-
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 1999 Apr;13(4):231-7. doi: 10.1046/j.1469-0705.1999.13040231.x. Ultrasound Obstet Gynecol. 1999. PMID: 10341399 Clinical Trial.
Similar articles
-
First trimester nuchal translucency: effective routine screening for Down's syndrome.Br J Radiol. 1999 Oct;72(862):946-8. doi: 10.1259/bjr.72.862.10673944. Br J Radiol. 1999. PMID: 10673944
-
Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.Ultrasound Obstet Gynecol. 1997 Oct;10(4):261-4. doi: 10.1046/j.1469-0705.1997.10040261.x. Ultrasound Obstet Gynecol. 1997. PMID: 9383877
-
Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.Ultrasound Obstet Gynecol. 1998 Sep;12(3):163-9. doi: 10.1046/j.1469-0705.1998.12030163.x. Ultrasound Obstet Gynecol. 1998. PMID: 9793187 Clinical Trial.
-
[Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].J Gynecol Obstet Biol Reprod (Paris). 1997;26(7):671-8. J Gynecol Obstet Biol Reprod (Paris). 1997. PMID: 9471429 Review. French.
-
First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?Ultrasound Obstet Gynecol. 1999 Apr;13(4):229-30. doi: 10.1046/j.1469-0705.1999.13040229.x. Ultrasound Obstet Gynecol. 1999. PMID: 10341398 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical